Business & Industry
Thermo Fisher to Acquire Clario Holdings for $8.9bn
Thermo Fisher to acquire Clario Holdings, the clinical trial data firm, for $8.9 billion in cash is in news and the same has been announced by the companies on October 29. Clario is at present held by a shareholder group...
Business & Industry
Simtra BioPharma Expands High-Quality Sterile Injectables
One of the leading contract development and manufacturing organization – CDMO that specializes in high-quality sterile injectables, Simtra BioPharma Solutions, has made tremendous progress on a dual-continent expansion strategy in order to meet the growing global demand for intricate...
News
Applications of the TXA2 Rat ELISA Kit in Cardiovascular Disease Research
The heart is a muscular organ responsible for circulating blood throughout the body. It ensures oxygen-rich blood reaches every tissue and organ and removes carbon dioxide and waste products from the body.
However, genetics, poor diet, sedentary lifestyle, exposure to...
News
5 Critical Challenges in Monoclonal Antibody Production
Monoclonal antibodies have completely revolutionized the field of modern medicine by offering targeted therapies for a range of diseases such as cancer, autoimmune disorders, and infectious diseases.
In fact, the global monoclonal antibody market is projected to reach USD 494.53...
Business & Industry
J&J To Be in Sync with Trump Administration as MFN Spreads
As the two Trump administration drug pricing deals find their place in the books and more that are likely on the way, the U.S. policy environment can very well soon stabilize for many Big Pharma companies. All this puts...
News
The Importance of Solar Energy in Securing a Sustainable Future for the Pharmaceutical Industry
In a time when sustainability and environmental consciousness are at the forefront of our global priorities, industries seek greener and cleaner energy solutions. The pharmaceutical sector is a vital community industry responsible for advancing healthcare and improving lives. It...
BioPharma
Investments in the U.S. of Over $70bn Announced by Merck
It is well to be noted that in 2025, a minimum of 14 major pharmaceutical companies across the world went ahead and announced plans to broaden their manufacturing presence in the U.S. so as to lessen the supply chain...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read